Future pulmonary rehabilitation perspectives following coronavirus disease 2019 in China

Hong-Mei Zhao,Peng-Ming Yu,Chen Wang
DOI: https://doi.org/10.1097/cm9.0000000000001700
IF: 6.133
2021-08-23
Chinese Medical Journal
Abstract:There is considerable evidence supporting the role of pulmonary rehabilitation as a safe and cost-effective component of integrated management in patients with chronic respiratory illness.[1] Despite extensive global guidelines endorsing pulmonary rehabilitation referral, a recent study in the United States revealed that only approximately 1.2% of patients with chronic obstructive pulmonary disease (COPD) have access to pulmonary rehabilitation services.[2] The reason cited by the authors for the low participation rate in pulmonary rehabilitation was an inadequate referral system. In China, pulmonary rehabilitation is in its infancy, and referral to a structured pulmonary rehabilitation program is less common compared with the developed countries.
medicine, general & internal
What problem does this paper attempt to address?